Chief Financial Officer
Kathy Yi has served as our Chief Financial Officer since June 2019.
Ms. Yi has over 18 years of experience in corporate finance, including financial analysis in support of M&A transactions, licensing and other business development activities. Previously, Ms. Yi served as executive vice president, chief financial officer and secretary of Sangamo Therapeutics, Inc., where she was responsible for leading the corporate finance, accounting, information technology and facility operations functions.
Prior to Sangamo Therapeutics, Ms. Yi was head of finance at Novartis Pharmaceutical Corporation and held various financial management positions of increasing seniority at Life Technologies Corp. and Intel Corp. Ms. Yi serves on the Board of Directors for Theseus Pharmaceuticals and in 2021 was named as one of Boston Business Journal’s CFOs of the Year.
She earned a B.S. in chemical engineering from the University of California, Berkeley, and an M.B.A. from Columbia Business School.